Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alenka Franko

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Radiology and Oncology|March 7, 2019
Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatmentBarbara Senk, Katja Goricar, Viljem Kovac, et al.
Radiology and Oncology|March 21, 2019
The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesotheliomaKristina Levpuscek, Katja Goricar, Viljem Kovac, et al.
Journal of Medical Biochemistry|June 19, 2020
NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseasesAlenka Franko, Katja Goricar, Viljem Kovac, et al.
Radiology and Oncology|February 5, 2021
The role of polymorphisms in glutathione-related genes in asbestos-related diseasesAlenka Franko, Katja Goricar, Metoda Dodic Fikfak, et al.
Radiology and Oncology|September 25, 2015
Fibulin-3 as a biomarker of response to treatment in malignant mesotheliomaViljem Kovac, Metoda Dodic-Fikfak, Niko Arneric, et al.
Disease Markers|March 2, 2012
Soluble mesothelin-related peptides levels in patients with malignant mesotheliomaAlenka Franko, Vita Dolzan, Viljem Kovac, et al.
Radiology and Oncology|March 19, 2020
Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseasesKatja Goricar, Viljem Kovac, Metoda Dodic-Fikfak, et al.
Disease Markers|October 10, 2015
Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant MesotheliomaKatja Goričar, Viljem Kovač, Alenka Franko, et al.
Radiology and Oncology|December 1, 2023
The association of genetic factors with serum calretinin levels in asbestos-related diseasesCita Zupanc, Alenka Franko, Danijela Strbac, et al.
Radiology and Oncology|October 21, 2020
The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesotheliomaPetra Piber, Neza Vavpetic, Katja Goricar, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Radiology and Oncology|March 7, 2019
Genetic polymorphisms in aquaporin 1 as risk factors for malignant mesothelioma and biomarkers of response to cisplatin treatmentBarbara Senk, Katja Goricar, Viljem Kovac, et al.
Radiology and Oncology|March 21, 2019
The influence of genetic variability of DNA repair mechanisms on the risk of malignant mesotheliomaKristina Levpuscek, Katja Goricar, Viljem Kovac, et al.
Journal of Medical Biochemistry|June 19, 2020
NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseasesAlenka Franko, Katja Goricar, Viljem Kovac, et al.
Radiology and Oncology|February 5, 2021
The role of polymorphisms in glutathione-related genes in asbestos-related diseasesAlenka Franko, Katja Goricar, Metoda Dodic Fikfak, et al.
Radiology and Oncology|September 25, 2015
Fibulin-3 as a biomarker of response to treatment in malignant mesotheliomaViljem Kovac, Metoda Dodic-Fikfak, Niko Arneric, et al.
Disease Markers|March 2, 2012
Soluble mesothelin-related peptides levels in patients with malignant mesotheliomaAlenka Franko, Vita Dolzan, Viljem Kovac, et al.
Radiology and Oncology|March 19, 2020
Evaluation of soluble mesothelin-related peptides and MSLN genetic variability in asbestos-related diseasesKatja Goricar, Viljem Kovac, Metoda Dodic-Fikfak, et al.
Disease Markers|October 10, 2015
Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant MesotheliomaKatja Goričar, Viljem Kovač, Alenka Franko, et al.
Radiology and Oncology|December 1, 2023
The association of genetic factors with serum calretinin levels in asbestos-related diseasesCita Zupanc, Alenka Franko, Danijela Strbac, et al.
Radiology and Oncology|October 21, 2020
The influence of genetic variability in IL1B and MIR146A on the risk of pleural plaques and malignant mesotheliomaPetra Piber, Neza Vavpetic, Katja Goricar, et al.
Pageof 3